Clinical Trials Browser

Phase 1 × Brain Neoplasms × anlotinib × Clear all

NCT05021328 2025-02-07

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

Phase 1 Completed

Brain Neoplasms